Sex-Specific Associations of Circulating Uric Acid with Risk of Diabetes Incidence: A Population-Based Cohort Study from Sweden

References

• Federation ID. IDF Diabetes Atlas. 9th. Brussels, Belgium; 2019.
   Google Scholar
• Imamura F, Mukamal KJ, Meigs JB, et al. Risk factors for type 2 diabetes mellitus preceded by beta-cell dysfunction, insulin resistance, or both in older adults: the Cardiovascular Health Study. Am J Epidemiol. 2013;177(12):1418–1429. doi:10.1093/aje/kws440
   PubMedGoogle Scholar
• Glumer C, Vistisen D, Borch-Johnsen K, Colagiuri S, Collaboration D. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care. 2006;29:410–414. doi:10.2337/diacare.29.02.06.dc05-0945
   PubMed Web of Science ®Google Scholar
• Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. BMJ. 2011;343(nov28 1):d7163. doi:10.1136/bmj.d7163
   PubMedGoogle Scholar
• Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007–2016. Arthritis Rheumatol. 2019;71:991–999. doi:10.1002/art.40807
   PubMed Web of Science ®Google Scholar
• Sattui SE, Singh JA, Gaffo AL. Comorbidities in patients with crystal diseases and hyperuricemia. Rheum Dis Clin North Am. 2014;40(2):251–278. doi:10.1016/j.rdc.2014.01.005
   PubMed Web of Science ®Google Scholar
• De Pergola G, Cortese F, Termine G, et al. Uric acid, metabolic syndrome and atherosclerosis: the chicken or the egg, which comes first? Endocr Metab Immune Disord Drug Targets. 2018;18:251–259. doi:10.2174/1871530318666180212101548
   PubMedGoogle Scholar
• Zupo R, Castellana F, Boninfante B, et al. Uric acid and potassium serum levels are independent predictors of blood pressure non-dipping in overweight or obese subjects. Nutrients. 2019;11(12):2970. doi:10.3390/nu11122970
   PubMed Web of Science ®Google Scholar
• Mortada I. Hyperuricemia, type 2 diabetes mellitus, and hypertension: an emerging association. Curr Hypertens Rep. 2017;19:69.
   PubMed Web of Science ®Google Scholar
• Li X, Meng X, Gao X, et al. Elevated serum xanthine oxidase activity is associated with the development of type 2 diabetes: a Prospective Cohort Study. Diabetes Care. 2018;41:884–890.
   PubMedGoogle Scholar
• Van der Schaft N, Brahimaj A, Wen K-X, Franco OH, Dehghan A, Hribal ML. The association between serum uric acid and the incidence of prediabetes and type 2 diabetes mellitus: the Rotterdam Study. PLoS One. 2017;12(6):e0179482. doi:10.1371/journal.pone.0179482
   PubMed Web of Science ®Google Scholar
• Bandaru P, Shankar A. Association between serum uric acid levels and diabetes mellitus. Int J Endocrinol. 2011;2011:604715. doi:10.1155/2011/604715
   PubMedGoogle Scholar
• Haque T, Rahman S, Islam S, Molla NH, Ali N. Assessment of the relationship between serum uric acid and glucose levels in healthy, prediabetic and diabetic individuals. Diabetol Metab Syndr. 2019;11:49.
   PubMedGoogle Scholar
• Keerman M, Yang F, Hu H, et al. Mendelian randomization study of serum uric acid levels and diabetes risk: evidence from the Dongfeng-Tongji cohort. BMJ Open Diabetes Res Care. 2020;8:e000834.
   PubMedGoogle Scholar
• Sluijs I, Holmes MV, van der Schouw YT, et al. A mendelian randomization study of circulating uric acid and type 2 diabetes. Diabetes. 2015;64(8):3028–3036. doi:10.2337/db14-0742
   PubMed Web of Science ®Google Scholar
• Shani M, Vinker S, Dinour D, et al. High normal uric acid levels are associated with an increased risk of diabetes in lean, normoglycemic healthy women. J Clin Endocrinol Metab. 2016;101(10):3772–3778. doi:10.1210/jc.2016-2107
   PubMedGoogle Scholar
• Choi BG, Kim DJ, Baek MJ, et al. Hyperuricaemia and development of type 2 diabetes mellitus in Asian population. Clin Exp Pharmacol Physiol. 2018;45:499–506. doi:10.1111/1440-1681.12911
   PubMedGoogle Scholar
• Berglund G, Elmstahl S, Janzon L, Larsson SA. The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med. 1993;233:45–51. doi:10.1111/j.1365-2796.1993.tb00647.x
   PubMedGoogle Scholar
• Hedblad B, Nilsson P, Janzon L, Berglund G. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden. Diabet Med. 2000;17(4):299–307. doi:10.1046/j.1464-5491.2000.00280.x
   PubMed Web of Science ®Google Scholar
• Rosvall M, Persson M, Ostling G, et al. Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: the Malmö Diet and Cancer Study. Atherosclerosis. 2015;239(2):615–621. doi:10.1016/j.atherosclerosis.2015.01.030
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. doi:10.1093/clinchem/18.6.499
   PubMed Web of Science ®Google Scholar
• Ali N, Perveen R, Rahman S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: a study on Bangladeshi adults. PLoS One. 2018;13(11):e0206850. doi:10.1371/journal.pone.0206850
   PubMed Web of Science ®Google Scholar
• Kodama S, Saito K, Yachi Y, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32(9):1737–1742. doi:10.2337/dc09-0288
   PubMed Web of Science ®Google Scholar
• Lv Q, Meng X-F, He -F-F, et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS One. 2013;8(2):e56864. doi:10.1371/journal.pone.0056864
   PubMed Web of Science ®Google Scholar
• Krishnan E, Akhras KS, Sharma H, et al. Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout. QJM. 2013;106(8):721–729. doi:10.1093/qjmed/hct093
   PubMed Web of Science ®Google Scholar
• Soltani Z, Rasheed K, Kapusta DR, Reisin E. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep. 2013;15(3):175–181. doi:10.1007/s11906-013-0344-5
   PubMed Web of Science ®Google Scholar
• Harrison R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med. 2002;33(6):774–797. doi:10.1016/S0891-5849(02)00956-5
   PubMed Web of Science ®Google Scholar
• Harrison R. Physiological roles of xanthine oxidoreductase. Drug Metab Rev. 2004;36(2):363–375. doi:10.1081/DMR-120037569
   PubMed Web of Science ®Google Scholar
• Matsuoka T, Kajimoto Y, Watada H, et al. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest. 1997;99:144–150. doi:10.1172/JCI119126
   PubMed Web of Science ®Google Scholar
• Jia L, Xing J, Ding Y, et al. Hyperuricemia causes pancreatic beta-cell death and dysfunction through NF-kappaB signaling pathway. PLoS One. 2013;8:e78284. doi:10.1371/journal.pone.0078284
   PubMed Web of Science ®Google Scholar
• Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41:1287–1293. doi:10.1161/01.HYP.0000072820.07472.3B
   PubMed Web of Science ®Google Scholar
• Lanaspa MA, Sanchez-Lozada LG, Choi YJ, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012;287:40732–40744. doi:10.1074/jbc.M112.399899
   PubMed Web of Science ®Google Scholar
• Baldwin W, McRae S, Marek G, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes. 2011;60:1258–1269. doi:10.2337/db10-0916
   PubMed Web of Science ®Google Scholar
• Sanchez-Lozada LG, Lanaspa MA, Cristobal-Garcia M, et al. Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations. Nephron Exp Nephrol. 2012;121(3–4):e71–8. doi:10.1159/000345509
   PubMedGoogle Scholar
• Prevention CfDCa. National Diabetes Statistics Reports 2020. Estimates of Diabetes and Its Burden in the United States. Department of Health and Human Services; 2020.
   Google Scholar
• Yang T, Ding X, Wang YL, et al. Association between high-sensitivity C-reactive protein and hyperuricemia. Rheumatol Int. 2016;36:561–566. doi:10.1007/s00296-016-3429-z
   PubMedGoogle Scholar
• Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab. 2012;38:183–191. doi:10.1016/j.diabet.2011.11.006
   PubMed Web of Science ®Google Scholar